Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss injections such as Mounjaro (tirzepatide) and Wegovy (semaglutide) do not burn fat directly. They work by changing the hormonal signals that govern hunger and fullness, which leads your body to consume less energy than it uses — and that deficit is what drives fat loss over time. Clinical trials published in the New England Journal of Medicine recorded average body-weight reductions of around 20–21% over 72 weeks at the highest tirzepatide dose. These are prescription-only medicines; a clinician assesses whether they are appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've probably seen the headlines, people losing a fifth of their body weight, fitting into clothes they last wore a decade ago. And then someone says the injection "burns fat" and you pause, because that sounds like something from a late-night infomercial. It's a fair reaction.
The honest answer is more interesting than either extreme. Mounjaro and Wegovy don't torch fat cells directly. What they do is change the conversation between your gut, your bloodstream and your brain, a conversation that, in many people living with obesity, has been stuck giving the wrong signals for years.
GLP-1 receptor agonists mimic a hormone your gut already produces after eating. When semaglutide (the medicine in Wegovy) binds to those receptors, your brain receives an earlier and stronger signal that you are full. Tirzepatide goes further by also activating GIP receptors, which influence both appetite and how fat tissue responds to insulin. The NHS medicines page for tirzepatide describes this dual action clearly. The outcome in practice: you eat less, often significantly less, without fighting a constant battle of willpower. Because your body is now taking in fewer calories than it needs each day, it turns to stored fat for energy. That is where the fat loss comes from.
There's also the gastric-emptying effect. Food moves more slowly from your stomach into your small intestine, so the physical sensation of fullness lasts longer than it would without the medicine. Between that and the hormonal signalling, many people find their relationship with food shifts in a way they haven't experienced before.
This question comes up constantly, and the short answer is no. Weight loss injections do not target a specific body area. Fat is mobilised wherever your body holds its reserves, in a pattern influenced by genetics, sex hormones and how long the fat has been stored.
People do often notice their waistline changing, partly because visceral fat (the metabolically active fat stored around the abdominal organs) tends to respond well to sustained calorie deficit, and if you want a thorough look at whether weight loss injections work specifically for belly fat, we cover the evidence in detail separately. That is a consequence of overall fat loss, not a directed action of the medicine. If you're curious about the distinction between fat reduction injections and the kind designed to reshape specific areas, the fat-dissolving injections page covers the difference.
The clinical trials that inform our understanding here involved thousands of adults and ran for 68–72 weeks. Results varied, as they always do in real populations. Some participants lost considerably more than the trial averages; others less. The medicine creates conditions in which fat loss becomes more achievable, it doesn't guarantee a fixed outcome for any individual. A prescriber assessing your health history is the right person to set realistic expectations.
For more on how results vary across different licensed injections, the weight-loss injections overview sets out the evidence side by side.
It's a reasonable challenge. If the mechanism is simply eating less, why not just eat less without the medicine?
Because hunger is not a choice. For many people with obesity, the brain's satiety signalling is persistently blunted, the "I've had enough" message never quite arrives at full volume. GLP-1 and GIP hormones play a direct role in that signalling, and in some people their natural levels or receptor responses are less effective than in others. These medicines don't override willpower; they correct, partially, a physiological gap.
There's also the matter of energy homeostasis. When people lose weight through calorie restriction alone, the body often responds by reducing its resting metabolism and intensifying hunger signals, a phenomenon sometimes called adaptive thermogenesis. Early research suggests GLP-1 medicines may partly counteract this adaptation, though the full picture is still being studied. The NHS England guidance on weight management injections reflects the clinical consensus that these medicines work best alongside a reduced-calorie diet and increased activity, not because the medicine alone is insufficient, but because lifestyle changes protect muscle mass and reinforce the metabolic benefits.
That said, these are prescription-only medicines, and the conversation about whether they suit your situation belongs with a clinician. Some people also ask about fat injections for weight loss, a term that covers a different category of treatment entirely, and understanding the distinction can help you ask the right questions when speaking to a prescriber. If you're weighing the options, a look at the three main licensed injections available in the UK might help frame the decision. On the question of cost (worth reading before you start comparing providers) the cheapest weight-loss injections page explains what legitimate pricing should include and what to watch for.
Disposal is worth thinking about from day one. A sharps container keeps used pen needles safe and is required by most local authority collection schemes.
If you'd like to understand whether treatment might be appropriate for your situation, check your eligibility with our prescribers, the consultation is free, and a GPhC-registered prescriber reads every response personally.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.